New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies.

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...

A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...

An international research team has deciphered a mechanism of the evolutionary arms race in human cells. The findings provide ...

Cell C, SA’s fourth-largest mobile operator, is capitalising on the strengths of its larger competitors, Vodacom and MTN, to ...

Ichnos Glenmark Innovation subsidiary IGI Therapeutics has signed an exclusive licensing agreement with AbbVie for ISB 2001, ...

The use of terms like 'beef' or 'salmon' on cultivated meat packaging labels helps – not hinders – consumer understanding, ...

TIGIT-targeting therapies have largely disappointed in recent months, with failed studies, terminated partnerships and ...